← Back to headlines
Boehringer Ingelheim's Obesity Drug Shows Promise in Late-Stage Trials
Boehringer Ingelheim's experimental obesity drug has demonstrated effectiveness in late-stage trials, significantly reducing harmful belly and liver fat.
7 Jun, 19:51 — 7 Jun, 19:51
Sources
Showing 1 of 1 sources
Related Stories
Extreme Training: What Heat Training Does to the Body
just now
Davao City Initiates Disinfection Operations Amidst Landfill Shutdown and Garbage Accumulation
just now
Advancements in Multiple Myeloma Treatment Improve Prognosis
29m ago
Thai Authorities Increase Ebola Surveillance Amid African Outbreaks
31m ago